Works matching IS 1607551X AND DT 2025 AND VI 41 AND IP 2


Results: 10
    1

    Real‐world efficacy and safety of universal 8‐week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre‐end‐stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan

    Published in:
    Kaohsiung Journal of Medical Sciences, 2025, v. 41, n. 2, p. 1, doi. 10.1002/kjm2.12929
    By:
    • Wang, Szu‐Jen;
    • Huang, Chung‐Feng;
    • Chang, Te‐Sheng;
    • Lo, Ching‐Chu;
    • Hung, Chao‐Hung;
    • Huang, Chien‐Wei;
    • Chong, Lee‐Won;
    • Cheng, Pin‐Nan;
    • Yeh, Ming‐Lun;
    • Peng, Cheng‐Yuan;
    • Cheng, Chien‐Yu;
    • Huang, Jee‐Fu;
    • Bair, Ming‐Jong;
    • Lin, Chih‐Lang;
    • Yang, Chi‐Chieh;
    • Kuo, Hsing‐Tao;
    • Hsieh, Tsai‐Yuan;
    • Lee, Tzong‐Hsi;
    • Lee, Pei‐Lun;
    • Wu, Wen‐Chih
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Issue Information.

    Published in:
    Kaohsiung Journal of Medical Sciences, 2025, v. 41, n. 2, p. 1, doi. 10.1002/kjm2.12856
    Publication type:
    Article